Medical directors of skilled nursing and long-term care sites say they’ve been scrambling to obtain doses of the antibody therapies following a change in federal policy that critics say limits supplies for the vulnerable population who remain at highest risk of COVID infection even after vaccination.
Join The Ecosystem